Hansa Biopharma publishes Annual Report 2022 ...Middle East

PR Newswire - News
LUND, Sweden., March 30, 2023 /PRNewswire/ -- Hansa Biopharma AB "Hansa" (STO TIDM: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release of the Annual Report 2022. Søren Tulstrup, President and CEO of Hansa Biopharma, comments: "2022 was a...

Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma publishes Annual Report 2022 )

Apple Storegoogle play

Also on site :